Molecules abaloparatide to cholecalciferol
100 molecules with a full cross-agency decision record, part of 534 published in total.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| abaloparatide | 7 | 7 | Calcium homeostasis |
| abatacept | 34 | 10 | Immunosuppressants |
| abemaciclib | 47 | 15 | Antineoplastics |
| abiraterone | 27 | 10 | Endocrine therapy |
| abrocitinib | 21 | 13 | Other dermatologicals |
| acalabrutinib | 52 | 14 | Antineoplastics |
| adalimumab | 133 | 11 | Immunosuppressants |
| adrenaline | 23 | 3 | Cardiac therapy |
| afatinib | 10 | 6 | Antineoplastics |
| aflibercept | 67 | 11 | Antineoplastics |
| alectinib | 37 | 15 | Antineoplastics |
| alemtuzumab | 12 | 8 | Immunosuppressants |
| alirocumab | 37 | 13 | Lipid modifying agents |
| alpelisib | 10 | 10 | Antineoplastics |
| alteplase | 10 | 5 | Antithrombotics |
| amifampridine | 7 | 5 | Other nervous system |
| amivantamab | 47 | 13 | Antineoplastics |
| anakinra | 19 | 7 | Immunosuppressants |
| andexanet alfa | 11 | 9 | Other therapeutic products |
| anidulafungin | 8 | 3 | Antimycotics |
| anifrolumab | 16 | 11 | Immunosuppressants |
| apalutamide | 28 | 12 | Endocrine therapy |
| apixaban | 31 | 11 | Antithrombotics |
| apomorphine | 13 | 4 | Urologicals |
| apremilast | 28 | 10 | Immunosuppressants |
| aprepitant | 20 | 6 | Antiemetics |
| aripiprazole | 41 | 8 | Psycholeptics |
| asciminib | 22 | 15 | Antineoplastics |
| asfotase alfa | 12 | 10 | Other alimentary tract and metabolism |
| ataluren | 13 | 8 | Other musculoskeletal |
| atazanavir | 12 | 4 | Antivirals |
| atezolizumab | 120 | 14 | Antineoplastics |
| atogepant | 19 | 13 | Analgesics |
| atomoxetine | 9 | 4 | Psychoanaleptics |
| avacopan | 16 | 11 | Immunosuppressants |
| avalglucosidase alfa | 13 | 10 | Other alimentary tract and metabolism |
| avapritinib | 30 | 11 | Antineoplastics |
| avatrombopag | 17 | 12 | Antihemorrhagics |
| avelumab | 42 | 13 | Antineoplastics |
| axicabtagene ciloleucel | 34 | 12 | Antineoplastics |
| axitinib | 9 | 8 | Antineoplastics |
| azacitidine | 25 | 11 | Antineoplastics |
| azithromycin | 13 | 5 | Antibacterials |
| baricitinib | 48 | 14 | Immunosuppressants |
| beclometasone | 23 | 4 | Antidiarrheals / intestinal anti-inflammatories |
| beclometasone / formoterol | 20 | 4 | Antidiarrheals / intestinal anti-inflammatories |
| beclometasone / formoterol / glycopyrronium | 13 | 5 | Antidiarrheals / intestinal anti-inflammatories |
| bedaquiline | 13 | 6 | Antimycobacterials |
| belantamab mafodotin | 21 | 10 | Antineoplastics |
| belimumab | 28 | 12 | Immunosuppressants |
| belzutifan | 18 | 13 | Antineoplastics |
| bempedoic acid | 8 | 6 | Lipid modifying agents |
| bendamustine | 23 | 6 | Antineoplastics |
| benralizumab | 31 | 15 | Obstructive airway diseases |
| berotralstat | 11 | 11 | Other hematological agents |
| betamethasone / calcipotriol | 7 | 4 | Antidiarrheals / intestinal anti-inflammatories |
| bevacizumab | 77 | 10 | Antineoplastics |
| bezlotoxumab | 10 | 7 | Immune sera and immunoglobulins |
| bilastine | 9 | 5 | Antihistamines |
| bimatoprost | 13 | 7 | Ophthalmologicals |
| bimatoprost / timolol | 8 | 4 | Ophthalmologicals |
| bimekizumab | 55 | 14 | Immunosuppressants |
| blinatumomab | 64 | 14 | Antineoplastics |
| bortezomib | 31 | 7 | Antineoplastics |
| bosentan | 21 | 6 | Antihypertensives |
| bosutinib | 16 | 10 | Antineoplastics |
| botulinum toxin type a | 14 | 4 | Muscle relaxants |
| brentuximab vedotin | 54 | 12 | Antineoplastics |
| brexpiprazole | 7 | 5 | Psycholeptics |
| brexucabtagene autoleucel | 19 | 8 | Antineoplastics |
| brigatinib | 25 | 14 | Antineoplastics |
| brivaracetam | 16 | 7 | Antiepileptics |
| brodalumab | 9 | 8 | Immunosuppressants |
| brolucizumab | 24 | 11 | Ophthalmologicals |
| budesonide | 76 | 12 | Antidiarrheals / intestinal anti-inflammatories |
| budesonide / formoterol | 22 | 4 | Obstructive airway diseases |
| bulevirtide | 15 | 11 | Antivirals |
| buprenorphine | 36 | 7 | Other nervous system |
| buprenorphine / naloxone | 16 | 6 | Other nervous system |
| burosumab | 34 | 13 | Bone diseases |
| cabazitaxel | 14 | 7 | Antineoplastics |
| cabotegravir | 25 | 10 | Antivirals |
| cabozantinib | 56 | 15 | Antineoplastics |
| canagliflozin | 13 | 8 | Diabetes |
| canakinumab | 31 | 10 | Immunosuppressants |
| cannabidiol | 35 | 12 | Antiepileptics |
| capecitabine | 13 | 5 | Antineoplastics |
| capivasertib | 11 | 9 | Antineoplastics |
| caplacizumab | 16 | 10 | Antithrombotics |
| capsaicin | 11 | 5 | Anesthetics |
| carfilzomib | 32 | 11 | Antineoplastics |
| ceftaroline fosamil | 8 | 4 | Antibacterials |
| ceftolozane / tazobactam | 8 | 4 | Antibacterials |
| cemiplimab | 55 | 13 | Antineoplastics |
| ceritinib | 17 | 9 | Antineoplastics |
| cerliponase alfa | 15 | 9 | Other alimentary tract and metabolism |
| certolizumab pegol | 43 | 11 | Immunosuppressants |
| cetuximab | 34 | 9 | Antineoplastics |
| chlormethine | 7 | 6 | Antineoplastics |
| cholecalciferol | 23 | 4 | Vitamins |